# OnCo record beyondspring (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/beyondspring/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "beyondspring" ;
  schema:name "BeyondSpring Pharmaceuticals"@en ;
  schema:alternateName "BeyondSpring Pharmaceuticals Inc."@en, "BeyondSpring"@en ;
  schema:description "BeyondSpring is a New York biotechnology company developing plinabulin, a microtubule-binding agent tested in phase 3 for chemotherapy-induced neutropenia and for non-small-cell lung cancer, which received a complete response letter from the FDA in 2021."@en ;
  schema:url <https://onco.cc/companies/beyondspring/>, <https://www.beyondspringpharma.com> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://www.beyondspringpharma.com>, <https://clinicaltrials.gov/search?lead=BeyondSpring> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/nsclc/> ;
  onco:sections <https://onco.cc/fronts/supportive-care/> ;
  onco:terms <https://onco.cc/terms/neutropenia/> .